Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nevro Corp (NY: NVRO )

148.62 USD -0.25 (-0.17%)
Streaming Delayed Price Updated: 3:56 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 182,459
Open 147.81
Bid (Size) 148.47 (1)
Ask (Size) 148.62 (1)
Prev. Close 148.87
Today's Range 145.56 - 148.77
52wk Range 109.30 - 188.14
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Nevro Appoints Jon R. Shear as Vice President, Corporate Development
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Jon Shear to the... 
From PR Newswire
Nevro to Present at BofA Securities 2021 Virtual Health Care Conference
Tuesday, May 11, 2021, at 2:00 pm Eastern Time / 11:00 am Pacific Time 
From PR Newswire

Performance

YTD
-13.36%
-13.36%
1 Month
+4.07%
+4.07%
3 Month
-16.36%
-16.36%
6 Month
-1.91%
-1.91%
1 Year
+26.49%
+26.49%

More News

Read More
Nevro to Report First Quarter 2021 Financial Results
From PR Newswire
Nevro Announces Publication Of Landmark SENZA-PDN Clinical Trial Results In JAMA Neurology
From PR Newswire
Nevro Reports Fourth Quarter and Full Year 2020 Financial Results
From PR Newswire
Nevro to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
From PR Newswire
Nevro to Present at 10th Annual SVB Leerink Global Healthcare Conference
From PR Newswire
Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results
From PR Newswire
Clinical Data Presented at 2021 North American Neuromodulation Society (NANS) Virtual Meeting Reinforce Significant Benefits of Nevro's HF10® Therapy
From PR Newswire
Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting
From PR Newswire
Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2020 Revenue
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.